Post-trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation

Pharmaceutical Companies vs. the State: Who is Responsible for Post-Trial Provision of Drugs in Brazil?

(2015) Daniel Wei L. Wang et al.   JOURNAL OF LAW MEDICINE & ETHICS

Edits to ethics code rankle

(2014) Heidi Ledford   NATURE

Protections for clinical trials in low and middle income countries need strengthening not weakening

(2014) R. Dal-Re et al.   BMJ-British Medical Journal

Engaging Diverse Social and Cultural Worlds: Perspectives on Benefits in International Clinical Research From South African Communities

(2013) Olga Zvonareva et al.   Developing World Bioethics

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

(2013) Yoram Unguru et al.   JOURNAL OF CLINICAL ONCOLOGY

Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare

(2013) Neema Sofaer et al.   JOURNAL OF MEDICAL ETHICS

Reconsidering the Declaration of Helsinki

(2013) Ezekiel J Emanuel   LANCET

Justifying Community Benefit Requirements in International Research

(2012) Robert C. Hughes   BIOETHICS

A Framework to Link International Clinical Research to the Promotion of Justice in Global Health

(2012) Bridget Pratt et al.   BIOETHICS

Fornecimento de medicamento investigacional após o fim da pesquisa clínica – Revisão da literatura e das diretrizes nacionais e internacionais

(2012) Sonia Mansoldo Dainesi et al.   Revista da Associacao Medica Brasileira

REALIZING BENEFIT SHARING - THE CASE OF POST-STUDY OBLIGATIONS

(2011) DORIS SCHROEDER et al.   BIOETHICS

Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review

(2011) N. Sofaer et al.   Public Health Ethics

How to Do Research Fairly in an Unjust World

(2010) Angela J. Ballantyne   AMERICAN JOURNAL OF BIOETHICS

'Relief of oppression': An organizing principle for researchers' obligations to participants in observational studies in the developing world

(2010) James V Lavery et al.   BMC PUBLIC HEALTH

POST-TRIAL ACCESS TO ANTIRETROVIRALS: WHO OWES WHAT TO WHOM?

(2009) JOSEPH MILLUM   BIOETHICS

Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study

(2009) N Sofaer et al.   JOURNAL OF MEDICAL ETHICS

Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?

(2008) Z. Zong   JOURNAL OF MEDICAL ETHICS